Free Trial
OTCMKTS:IPCIF

Intellipharmaceutics International (IPCIF) Stock Price, News & Analysis

Intellipharmaceutics International logo

About Intellipharmaceutics International Stock (OTCMKTS:IPCIF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
12,042 shs
Market Capitalization
$4.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IPCIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

IPCIF Stock News Headlines

Intellipharmaceutics International Inc. (IPCI.TO)
Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
See More Headlines

IPCIF Stock Analysis - Frequently Asked Questions

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) posted its quarterly earnings data on Monday, July, 16th. The company reported ($0.70) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.70). The company had revenue of $0.58 million for the quarter, compared to analyst estimates of $0.90 million.

Intellipharmaceutics International shares reverse split before market open on Friday, September 14th 2018.The 1-10 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of IPCIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/16/2018
Today
8/23/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IPCIF
CIK
1474835
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$660 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.32) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
33,093,000
Free Float
32,511,000
Market Cap
$4.96 million
Optionable
Not Optionable
Beta
1.53
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:IPCIF) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners